PURPLE BIOTECH LTD. Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity
PURPLE BIOTECH LTD. (PPBT) reported Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity of $17.83 million for the 12-month period ending 2021-12-31, per its 20-F filed 2023-03-03.
Discontinued › Notes
ifrs-full:ProfitLossFromContinuingOperationsAttributableToOrdinaryEquityHoldersOfParentEntity · last filed 2023-03-03
| Period end | Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders Of Parent Entity 12 month |
|---|---|
| 2021-12-31 | $17.83M 20-F · filed 2023-03-03 |
| 2020-12-31 | $28.70M 20-F · filed 2023-03-03 |